Clinical features and classification of Seasonal endophthalmitis Seasonal hyperacute Panuveits based on the largest outbreak cases in Nepal
This retrospective study of 123 cases from the 2015–2016 Nepal outbreaks characterizes Seasonal Hyperacute Panuveitis (SHAPU) as an endophthalmitis-like condition with distinct clinical features that evolve over time, concluding that disease severity should be assessed based on specific clinical findings rather than the duration of symptoms to guide effective management.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
In the high, rolling hills of Nepal, a unique and terrifying eye disease strikes children with frightening speed. Known locally as seasonal hyperacute panuveitis, or SHAPU, this condition causes sudden, severe inflammation inside the eye, often leading to permanent blindness in just one eye. For decades, doctors have debated what this illness actually is. The name suggests it is a form of panuveitis, a broad inflammation affecting all layers of the eye's interior. However, the speed at which it destroys vision and the specific way it spreads through the eye's fluids have long hinted that it might be something more aggressive, perhaps a rapid infection similar to endophthalmitis, a condition usually caused by bacteria entering the eye after surgery or injury. Understanding the true nature of this disease is critical because the treatment for a general inflammation differs vastly from the urgent, aggressive intervention required for a severe infection. If doctors misjudge the severity or the type of disease based on how long a child has been sick, they may delay the life-saving treatment needed to save a child's sight.
A team of researchers at the Tilganga Institute of Ophthalmology in Nepal set out to solve this puzzle by studying the largest outbreak of the disease ever recorded, which occurred between 2015 and 2016. They gathered detailed records from 123 children who arrived at their hospital with the condition. Instead of just looking at the final outcome, the team carefully examined the specific signs present in each child's eye, such as the presence of pus, cloudiness in the fluid, and the appearance of the back of the eye, and they grouped these children based on how many days they had been sick before seeking help. They divided the cases into three groups: those who arrived within two days of symptoms starting, those who came between three and seven days, and those who arrived after more than a week. By comparing the physical signs across these different timeframes, the researchers hoped to create a clear, evidence-based guide for how to classify and treat the disease, moving beyond old assumptions that relied solely on how long the patient had been suffering.
The study revealed that the disease behaves much more like a severe infection than a simple inflammation. When the children arrived at the hospital, many showed signs of intense distress, including significant pain, crying, and irritability, which challenged the older belief that the condition was painless. The most striking finding was that the severity of the disease did not depend on how long the child had been sick. Even among the children who arrived very early, within just two days of symptoms starting, the eyes were already in a state of severe crisis. Nearly ninety percent of these early cases had a visible collection of white pus in the front of the eye, a sign of intense infection, and over half of them had already lost most of their vision. This directly contradicts the idea that early cases are mild or that the disease starts gently and only becomes dangerous after a week. In fact, the researchers found that the most dangerous signs, such as the presence of bacteria in the eye fluid, were just as common in the early group as they were in the late group.
As the disease progressed over time, the nature of the symptoms changed, but not in the way doctors had previously thought. In the early stages, the fluid inside the eye often looked clear or colorless when sampled, and the back of the eye still glowed with a bright red reflection when light was shone into it. However, as the days passed, the fluid became cloudy and thick, and that red glow was replaced by a white or greenish-white reflex, a sign that the view into the back of the eye was blocked by debris and inflammation. The researchers also found that the tissue at the very back of the eye, which supports the retina, became thickened and swollen in more than half of the cases, particularly in those who arrived later. This thickening, combined with the rapid spread of cloudiness throughout the eye, strongly suggested that the disease was an endophthalmitis, an infection that spreads through the entire eye, rather than a panuveitis that stays confined to the walls of the eye.
The team also discovered that the presence of a white moth, suspected to be the cause of the outbreak, was not always obvious, but the damage it caused was undeniable. In many cases, tiny hairs from the moth were found on the surface of the eye, likely introducing toxins or bacteria that triggered the violent reaction. The study showed that the disease could strike with such ferocity that a child could arrive with a clear view of the back of the eye, only to lose that view and suffer severe vision loss within a few days. This rapid progression meant that waiting to see if the condition would get worse was not an option. The researchers concluded that doctors should not wait for the classic signs of a late-stage infection, such as a white reflex or a completely blocked view, to begin treatment. Instead, they must judge the severity of the disease based on the immediate clinical signs present at the moment the patient arrives, regardless of whether the child has been sick for one day or ten.
This new understanding provides a vital roadmap for ophthalmologists treating these children. By recognizing that the disease is an aggressive infection that can be severe from the very first day, doctors can act faster and more decisively. The study confirms that the old classification system, which labeled early cases as mild and late cases as severe, was misleading. A child presenting early can be just as sick as one presenting late, and the treatment must reflect that reality. The findings from this large outbreak in Nepal offer a clearer, more accurate way to identify and manage this blinding condition, ensuring that children receive the urgent care they need to preserve their vision before it is too late.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.